European Journal of Nuclear Medicine and Molecular Imaging
Journal Abbreviation: EUR J NUCL MED MOL I
ISSN: 1619-7070
Publisher: Springer Verlag (Germany)
Publications (75)
Zirconium-89-based PSMA PET/CT with delayed imaging for early detection of biochemical recurrence in prostate cancer patients with PSA ≤ 0.2 ng/mL: A feasibility study (2026)
Speicher T, Latell S, Blickle A, Bastian MB, Maus S, Schaefer-Schuler A, Bartholomä M, et al.
Journal article
Comparison of mCRPC [177Lu]Lu-PSMA-617 radioligand therapy with and without concurrent enzalutamide medication in a real-world setting (2026)
Rosar F, Khreish F, Burgard C, Fursov A, Blickle A, Bartholomä M, Maus S, et al.
Journal article
Sex-specific differences in patients with differentiated thyroid carcinoma and their possible impact on survival (2026)
Heinrich M, Blickle E, Jedamzik T, Kohnle P, Kerscher A, Verburg FA, Buck AK, Michalski K
Journal article
Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysis (2026)
Wollnitza S, Ventura D, Teichert M, Freisleben F, Boyadzhiev H, Seifert R, Amon M, et al.
Journal article
Real-world evaluation of [177Lu]Lu-PSMA-617 RLT in post-taxane mCRPC: feasibility and safety of individualized treatment in a challenging cohort (2026)
Misirci M, Rosar F, Khreish F, Burgard C, Blickle A, Bartholomä M, Maus S, et al.
Journal article
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy? (2026)
Pillong L, Burgard C, Rosar F, Demirkol B, Ebner R, Linxweiler M, Bozzato A, et al.
Journal article
Expanding the scope of PSMA-RLT: evaluating treatment in challenging mCRPC patients with poor performance status (ECOG 3) (2025)
Bastian MB, Wörl B, Blickle A, Burgard C, Speicher T, Bartholomä M, Schaefer-Schuler A, et al.
Journal article
PSMA PET/CT in biochemical recurrence of prostate cancer with PSA levels ≤ 0.2 ng/mL: a German multicenter analysis of conventional PSMA tracers, including [68Ga]Ga-PSMA-11, [68Ga]Ga-PSMA I&T, and [18F]PSMA-1007 (2025)
Burgard C, Frei M, Blickle A, Hartrampf PE, Hoffmann MA, Schreckenberger M, Schmid HP, et al.
Journal article
[68Ga]Ga-FAPI-04 PET/CT in a patient with endometriosis: a potential game changer? (2025)
Burgard C, Rosar F, Ezziddin S, Hamoud BH, Solomayer EF, Laschke MW, Constantin A, Bartholomä M
Journal article
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study (2025)
Unterrainer LM, Farolfi A, Grogan T, Hotta M, Djaileb L, Gafita A, Sonni I, et al.
Journal article